Infectious Disease News Current Issue

The following articles appeared in the print edition of Infectious Disease News.

Table of Contents

• CRE deemed ‘nightmare’ bacteria by CDC
• Additional research needed of post-infectious irritable bowel syndrome Herbert L. DuPont, MD, MACP
• Pivotal strategies in smallpox eradication D.A Henderson, MD, MPH
• ACIP recommends Japanese encephalitis vaccine for travelers
• ACIP: Second dose of Tdap not recommended
• Age disparities found across HIV continuum of care
• High HCV transmission rates among MSM found early in HIV epidemic
• Potential role of flu vaccines, respiratory illness unknown
• PrEP effective in injection drug users
• UTI symptoms often improved for women 
who delayed antibiotics
• WHO convenes IHR Emergency Committee for MERS
• Travel medicine: Recommendations for 
specific at-risk travelers Deepak Kamat, MD, PhD, FAAP
• Conventional wisdom of influenza A; 
a historical perspective Donald Kaye, MD, MACP; Theodore C. Eickhoff, MD
• FDA approves four-strain influenza vaccine
• Dengue outbreak continues in Angola
• CDC recommends PrEP for injection drug users
• Double dose of oseltamivir had no advantage in severe influenza
• Emerging staphylococcal strain found in community, hospital settings
• Examining worldwide disease trends can help guide travelers
• Cambodia seeks to halt progression of HIV by 2020
• Maraviroc shows promise in HIV-infected children
• WHO: Earlier ART could prevent 3 million HIV deaths
• New, novel treatment of multidrug-resistant Mycobacterium tuberculosis Kimberly Boeser, PharmD, MPH, BCIDP